Faranak Jelvehzadeh1, Ebrahim Rezaei Dogaheh1, Colleen Bernstein2, Shima Shakiba1, Hadi Ranjbar3. 1. Department of Psychology, School of Behavioral Sciences, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. 2. University of the Witwatersrand, Johannesburg, South Africa. 3. Mental Health Research Center, Psychosocial Health Research Institute, Iran University of Medical Sciences, Shahid Mansouri st, Niyayesh st, Sattarkhan Ave, Tehran, Iran. Ranjbar.h@iums.ac.ir.
Abstract
PURPOSE: While the rate of survival has increased in the past decade, the diagnosis of breast cancer is an extremely stressful experience for patients and it is associated with the manifestation of several psychological problems. To examine the effect of a group cognitive behavioral therapy (CBT) on the quality of life and emotional disturbance of women with breast cancer. METHODS: The study was a randomized controlled clinical trial. Samples were 48 women who had been diagnosed with breast cancer and had undergone mastectomy and chemotherapy. Study variables were measured before and after the intervention and 1 month after the end of the intervention as a follow-up. Controls received nothing and were just followed-up. Repeated measure ANOVAs were used to compare the effectiveness of the intervention on the study variables. RESULTS: The results of 32 women were analyzed. The increase in quality of life scores was significantly higher in the intervention group compared to the control group (P < 0.05). There were also significantly lower changes in the depression, anxiety, and stress scores of the intervention group (P < 0.05). However, the changes in the score of death anxiety were not significantly lower in the intervention group in comparison to controls (P > 0.05). CONCLUSION: Group cognitive behavioral therapy was effective in the improvement of quality of life and decreases some aspects of emotional disturbance. Findings of this study suggest that women with breast cancer can benefit from group CBT. Yet, some aspects of the mental health of these women may need more attention and individualized methods. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: IRCT20100911004728N4.
PURPOSE: While the rate of survival has increased in the past decade, the diagnosis of breast cancer is an extremely stressful experience for patients and it is associated with the manifestation of several psychological problems. To examine the effect of a group cognitive behavioral therapy (CBT) on the quality of life and emotional disturbance of women with breast cancer. METHODS: The study was a randomized controlled clinical trial. Samples were 48 women who had been diagnosed with breast cancer and had undergone mastectomy and chemotherapy. Study variables were measured before and after the intervention and 1 month after the end of the intervention as a follow-up. Controls received nothing and were just followed-up. Repeated measure ANOVAs were used to compare the effectiveness of the intervention on the study variables. RESULTS: The results of 32 women were analyzed. The increase in quality of life scores was significantly higher in the intervention group compared to the control group (P < 0.05). There were also significantly lower changes in the depression, anxiety, and stress scores of the intervention group (P < 0.05). However, the changes in the score of death anxiety were not significantly lower in the intervention group in comparison to controls (P > 0.05). CONCLUSION: Group cognitive behavioral therapy was effective in the improvement of quality of life and decreases some aspects of emotional disturbance. Findings of this study suggest that women with breast cancer can benefit from group CBT. Yet, some aspects of the mental health of these women may need more attention and individualized methods. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: IRCT20100911004728N4.
Authors: Andrea Chirico; Fabio Lucidi; Thomas Merluzzi; Fabio Alivernini; Michelino De Laurentiis; Gerardo Botti; Antonio Giordano Journal: Oncotarget Date: 2017-05-30
Authors: Lauren C Brown; Amy R Murphy; Chloe S Lalonde; Preeti D Subhedar; Andrew H Miller; Jennifer S Stevens Journal: Cancer Date: 2020-05-06 Impact factor: 6.921
Authors: Roya Dolatkhah; Mohammad Hossein Somi; Mohammad Asghari Jafarabadi; Mehrnaz Hosseinalifam; Sepideh Sepahi; Mina Belalzadeh; Marzieh Nezamdoust; Saeed Dastgiri Journal: Int J Breast Cancer Date: 2020-05-01
Authors: Miguel A Alvarez-Mon; Cesar Ignacio Fernandez-Lazaro; Miguel A Ortega; Cristina Vidal; Rosa M Molina-Ruiz; Melchor Alvarez-Mon; Miguel A Martínez-González Journal: Front Psychiatry Date: 2022-05-18 Impact factor: 5.435